Subject: Fwd: Deal Prospect - Roboteam
From: "Neil Callahan" <[email-masked]>
To: "Hunter Biden" <[email-masked]>
Date: Tue, 20 May 2014 01:53:38 -0400

Good call - I gave him an FYI below.

--------------------
Neil Callahan
Rosemont Seneca
917-945-9516

Begin forwarded message:

> From: Neil Callahan <[email-masked]>
> Date: May 20, 2014 at 1:51:20 AM EDT
> To: Chris Heinz <[email-masked]>
> Subject: Fwd: Deal Prospect - Roboteam
> Check this one out.   Good fit for growth-tech, solid company.   Will start to take a deeper look later this week.
> 
> --------------------
> Neil Callahan
> Rosemont Seneca
> 917-945-9516
> 
> Begin forwarded message:
> 
>> From: Neil Callahan <[email-masked]>
>> Date: May 19, 2014 at 5:33:07 PM EDT
>> To: William Lee <[email-masked]>, John DeLoche <[email-masked]>, Devon Archer <[email-masked]>, Rob Walker <[email-masked]>, Hunter Biden <[email-masked]>
>> Subject: Deal Prospect - Roboteam
>> Hey guys,
>> 
>> Take a look at Roboteam.
>> 
>> They are in the unmanned systems space (i.e., robotics, drones, etc.)
>> 
>> Strong adoption by the US Military, Law Enforcement and First Responders.
>> 
>> Genesis is R&D/Tech from the Israeli military (tech has been used in fighting in the tunnels of Lebanon and Sinai where Iran has put thousands of missiles and military supplies).
>> 
>> Financials meet our criteria:
>> Did $12.2m in revenue in '13 with $1.1m of EBITDA.  Did $4.8m in revenue in '12.
>> '14 plan is to do $20m in revenue (greater than 50% growth) and $3m of EBITDA.
>> Projected $115m in new orders in '15/'16.
>> 
>> Strong exit potential to folks like Google, Amazon, and the military contractors who are all investing in robotics and unmanned systems technologies.
>> 
>> Currently and Israeli company, but open to establishing as a US company, to be discussed.
>> 
>> No institutional investors to date.
>> 
>> RSTP value add in helping them grow is clear.
>> 
>> Looking to raise $5-15m to build out to capture current demand.
>> 
>> Take a look and let me know if you want to have a call to review.
>> 
>> Best,
>> 
>> Neil
>> 
>> 
>> -- 
>> Neil Callahan
>> Rosemont Seneca Partners
>> 917-945-951